3 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow Tolerability: new trials by email Literature Review of Tolerability trials Research Report on Tolerability
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults Nezavist SDD, Placebo - Healthy, Safety Evaluation of Escalating Doses | Phase 1 | Terminated | Lohocla Research Corporation | 29 | 2025-02-28 | 2026-09-08 |
| TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms MDG1011, Investigator Choice therapy - Safety, Tolerability | Phase 1 / Phase 2 | Terminated | Medigene AG | 9 | 2018-03-27 | 2023-02-15 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants MLN3126, MLN3126 Matched Placebo - Safety, Tolerability | Phase 1 | Terminated | Takeda | 23 | 2014-07-01 | 2016-07-25 |
microcrystalline cellulose (1)
Lohocla Research Corporation (1) · Medigene AG (1) · Takeda (1)
United States (2) · Germany (1)
Mark Wallace, MD (1) · Simone Thomas, PD Dr. med. (1)
R44AA024905 (1)